AIDS-related risk behaviour, polydrug use and temazepam. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS-related risk behaviour, polydrug use and temazepam.

Br J Addict. 1990 Sep;85(9):1125-32. Unique Identifier : AIDSLINE MED/91028320
Klee H; Faugier J; Hayes C; Boulton T; Morris J; Faculty of Community Studies, Manchester Polytechnic, UK.

Abstract: In a study of AIDS-related risk behaviour among injecting drug users in the north west of England it was found that 90% were polydrug users, and 28% were using temazepam. A third of all polydrug users had regularly used more than three drugs in addition to their preferred drug in the previous year. Statistical analysis revealed that the use of temazepam and extensive polydrug use were associated with sharing injecting equipment. Significant associations were also found with indices of sexual risk behaviour. It was concluded that multiple drug use and the use of temazepam were associated with behaviour that could increase exposure to HIV infection.
Keywords: Acquired Immunodeficiency Syndrome/PSYCHOLOGY/*TRANSMISSION Adolescence Adult Female *Health Behavior Human Male *Risk-Taking Street Drugs Substance Abuse, Intravenous/*COMPLICATIONS/PSYCHOLOGY Substance Dependence/*COMPLICATIONS/PSYCHOLOGY Support, Non-U.S. Gov't *Temazepam JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/psychology/KWDtransmissionadolescenceadultfemaleKWDhealthbehaviorhumanmaleKWDrisk-takingstreetdrugssubstanceabuse,intravenous/KWDcomplications/psychologysubstancedependence/KWDcomplications/psychologysupport,non-uKWDsKWDgov'tKWDtemazepamjournalarticle
910228
M9120665

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .